Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK
Titel:
Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK
Auteur:
Borner, M. Koeberle, D. Von Moos, R. Saletti, P. Rauch, D. Hess, V. Trojan, A. Helbling, D. Pestalozzi, B. Caspar, C. Ruhstaller, T. Roth, A. Kappeler, A. Dietrich, D. Lanz, D. Mingrone, W.